Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:
新泽西贝德明斯特，2024年11月19日（环球新闻社）--Intra-Cellular Therapies, Inc.（纳斯达克: ITCI），一家专注于中枢神经系统（CNS）疾病治疗药物开发和商业化的生物制药公司，今日宣布首席执行官兼董事长Sharon Mates博士将在三个即将举行的投资者会议上发表演讲:
Evercore 7th Annual HealthCONx Conference
Tuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL
Evercore第7届年度HealthCONx会议
2024年12月3日星期二，美国东部时间上午10:50，在佛罗里达州迈阿密
Citi 2024 Global Healthcare Conference
Wednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL
Citi 2024全球医疗保健会议
2024年12月4日星期三，美国东部时间下午3:15，在佛罗里达州迈阿密
Piper Sandler 36th Annual Healthcare Conference
Thursday, December 5, 2024 at 11:30 a.m. ET in New York, NY
派杰投资第36届医疗保健年会
2024年12月5日星期四上午11:30美国东部时间在纽约市
A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website at . Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
您可以在公司网站的投资者部门的"活动与演示"下访问演示的直播和存档网络广播。请在活动开始前约5-10分钟登录注册，并下载并安装必要的软件。
About Intra-Cellular Therapies
关于Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit .
Intra-Cellular Therapies是一家基于诺贝尔奖获奖研究创立的生物制药公司，可以让我们了解疗法如何影响身体内部的细胞工作原理。该公司利用这种细胞内方法开发创新治疗方法，为患有复杂精神和神经疾病的患者提供帮助。欲了解更多信息，请访问。
Contact:
联系方式：
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Intra-Cellular Therapies，Inc.
Juan Sanchez博士
副总裁，企业传媒和投资者关系
646-440-9333.
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406
Burns McClellan，Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406.